SEC Filing Summary: Movano Inc. (MOVE) - Form 10-Q
Business Context and Reporting Period
Company: Movano Inc. (dba Movano Health)
Reporting Period: Quarter and nine months ended September 30, 2025
Business Overview: Movano is a technology company developing medical-grade consumer health devices, primarily the "Evie Ring" for women's health and the "EvieMED Ring" (FDA-cleared for pulse oximetry). The company is currently in a pre-revenue growth stage with significant operational losses.
Corporate Status: The company is a non-accelerated filer, smaller reporting company, and emerging growth company. It completed a 1-for-10 reverse stock split on October 10, 2025, to regain Nasdaq compliance.
Key Financial Metrics
| Metric (in thousands) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Revenue | $80 | $50 | $389 | $902 |
| Net Loss | $(4,029) | $(7,201) | $(12,432) | $(19,111) |
| Loss Per Share (Basic/Diluted) | $(4.73) | $(10.56) | $(15.91) | $(33.34) |
| Cash and Cash Equivalents | $2,000 | $11,272 | $2,000 | $11,272 |
| Total Assets | $5,557 | $11,320 | $5,557 | $11,320 |
| Total Liabilities | $7,258 | $3,965 | $7,258 | $3,965 |
| Stockholders' Equity (Deficit) | $(1,701) | $10,251 | $(1,701) | $10,251 |
| Net Cash Used in Operating Activities (9M) | $(9,008) | $(17,978) | $(9,008) | $(17,978) |
Debt & Liquidity: As of September 30, 2025, the company held a $1.5 million bridge loan (related party) with a carrying value of $3.0 million due to a $3.0 million original issue discount/premium. The loan bears an effective annual interest rate of approximately 532.59%.
Material Changes vs. Prior Period
- Revenue Decline: Nine-month revenue decreased 57% to $0.4 million from $0.9 million in the prior year, attributed to reduced marketing efforts and lower sales volume of the Evie Ring.
- Expense Reduction: Total operating expenses decreased 44% year-over-year for the nine-month period, driven by lower headcount, reduced R&D laboratory expenses, and decreased marketing costs.
- Net Loss Improvement: Despite the revenue drop, the net loss narrowed by 35% for the nine months ended September 30, 2025, primarily due to the significant reduction in operating expenses.
- Bridge Loan Impact: The company incurred $1.5 million in interest expense (related party) in Q3 2025 due to the amortization of the original issue discount on the August 2025 bridge loan. This was a new expense item not present in the prior year.
- Equity Deficit: The company moved from positive equity ($10.3 million) in Q3 2024 to a deficit of $1.7 million in Q3 2025, driven by accumulated losses and the recognition of the bridge loan liability.
Guidance, Outlook, and Risks
Merger Agreement: On November 6, 2025, Movano entered into a definitive merger agreement with Corvex, Inc. Under the terms, Corvex shareholders will own approximately 96.2% of the combined company, while Movano shareholders will own approximately 3.8%. The transaction is expected to close in Q1 2026.
Financing Activities:
- Series A Financing: Raised $3.0 million in preferred stock in November 2025.
- Equity Facility: Entered into a $1.0 billion equity facility with Chardan Capital Markets, subject to SEC registration effectiveness.
- Bridge Loan Extension: The bridge loan maturity was extended to March 31, 2026, contingent on the merger closing or asset disposition.
Going Concern: Management has raised substantial doubt about the company's ability to continue as a going concern. Cash on hand ($2.0 million) plus the Series A proceeds ($3.0 million) is projected to be insufficient to fund operations beyond Q1 2026 without the successful consummation of the merger or additional capital raises.
Risks:
- Nasdaq Compliance: The company recently regained compliance with Nasdaq bid price and filing requirements but remains non-compliant with the $2.5 million stockholders' equity requirement.
- Merger Uncertainty: Failure to close the merger could lead to insolvency, liquidation, or bankruptcy.
- Internal Controls: The company disclosed material weaknesses in internal controls over financial reporting, including ineffective IT general controls and process-level controls.
Investor Verification Checklist
- Merger Closing Conditions: Verify the status of shareholder approvals and regulatory clearances required to close the Corvex merger.
- Bridge Loan Terms: Confirm the repayment obligations and the risk of asset forfeiture if the merger fails to close by the March 31, 2026 maturity date.
- Equity Dilution: Assess the impact of the merger exchange ratio, where existing Movano shareholders will retain only ~3.8% ownership.
- Nasdaq Listing Status: Monitor the company's ability to meet the $2.5 million stockholders' equity requirement to avoid delisting.
- Internal Control Remediation: Review the company's plan to address the material weaknesses in financial reporting controls.